JP2008519838A - 遺伝子調節のための酸化防止剤の使用 - Google Patents

遺伝子調節のための酸化防止剤の使用 Download PDF

Info

Publication number
JP2008519838A
JP2008519838A JP2007541282A JP2007541282A JP2008519838A JP 2008519838 A JP2008519838 A JP 2008519838A JP 2007541282 A JP2007541282 A JP 2007541282A JP 2007541282 A JP2007541282 A JP 2007541282A JP 2008519838 A JP2008519838 A JP 2008519838A
Authority
JP
Japan
Prior art keywords
genes
gene
gene encoding
products
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007541282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519838A5 (https=
Inventor
ズィッカー，スティーヴン・カーティス
ペートウ−ロビンソン，インケ
ウェーデキンド，カレン・ジョイ
Original Assignee
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヒルズ・ペット・ニュートリシャン・インコーポレーテッド filed Critical ヒルズ・ペット・ニュートリシャン・インコーポレーテッド
Publication of JP2008519838A publication Critical patent/JP2008519838A/ja
Publication of JP2008519838A5 publication Critical patent/JP2008519838A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
JP2007541282A 2004-11-09 2005-11-09 遺伝子調節のための酸化防止剤の使用 Pending JP2008519838A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62616204P 2004-11-09 2004-11-09
PCT/US2005/040515 WO2006053010A2 (en) 2004-11-09 2005-11-09 Use of antioxidants for gene modulation

Publications (2)

Publication Number Publication Date
JP2008519838A true JP2008519838A (ja) 2008-06-12
JP2008519838A5 JP2008519838A5 (https=) 2009-01-15

Family

ID=39012035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007541282A Pending JP2008519838A (ja) 2004-11-09 2005-11-09 遺伝子調節のための酸化防止剤の使用

Country Status (10)

Country Link
US (1) US11077165B2 (https=)
EP (1) EP1814394A4 (https=)
JP (1) JP2008519838A (https=)
CN (2) CN101098623B (https=)
AU (1) AU2005304546B2 (https=)
BR (1) BRPI0517563A (https=)
CA (1) CA2586936C (https=)
RU (1) RU2433819C2 (https=)
WO (1) WO2006053010A2 (https=)
ZA (1) ZA200704210B (https=)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011528556A (ja) * 2008-07-18 2011-11-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢の動物の生活の質を向上させるための方法
JP2011528555A (ja) * 2008-07-18 2011-11-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢の動物の生活の質を向上させるための方法
JP2012513766A (ja) * 2008-12-30 2012-06-21 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルにおける変性関節病、骨関節炎、軟骨損傷、および関連する障害を処置する、または予防する方法
JP2012513767A (ja) * 2008-12-30 2012-06-21 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド リポ酸を含むコンパニオンアニマル用組成物およびその使用の方法
JP2013532128A (ja) * 2010-05-12 2013-08-15 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 愛玩動物の炎症を抑制および予防し、炎症状態を緩和する方法
JP2013172732A (ja) * 2006-09-01 2013-09-05 Hill's Pet Nutrition Inc 動物用食物組成物を設計するための方法およびシステム
JP2014018172A (ja) * 2012-07-20 2014-02-03 Kohjin Life Sciences Co Ltd 過酸化脂質生成を抑制するペットフード

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2433819C2 (ru) 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Применение антиоксидантов для модуляции генов
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
CN101287460B (zh) 2005-08-17 2012-04-25 希尔氏宠物营养品公司 预防和治疗肾病的组合物
CN100462074C (zh) * 2007-02-14 2009-02-18 北京东方兴企食品工业技术有限公司 一种具有缓解视疲劳作用的口嚼片
EP2323638B1 (en) * 2008-07-18 2014-05-07 Hill's Pet Nutrition, Inc. Compositions and methods for treating osteoarthritis
WO2010078319A1 (en) * 2008-12-30 2010-07-08 Hill's Pet Nutrition, Inc. Lipoic acid containing compositions for use in the treatment and prevention of ki dney- related disorders in companion animals
WO2011084886A1 (en) * 2010-01-06 2011-07-14 Nestec S. A. Dietary regimens useful for mimicking caloric restriction
CA2795726A1 (en) * 2010-04-06 2011-10-13 Edison Pharmaceuticals, Inc. Treatment of ataxia telangiectasia
CN102884434B (zh) 2010-05-12 2015-08-19 希尔氏宠物营养品公司 用于诊断、控制和预防犬科动物炎症及减轻犬科动物炎性病况的方法
US20120282373A1 (en) * 2011-05-02 2012-11-08 Ashok Premchand Luhadiya Compositions Comprising a Glucose Anti-Metabolite and Selenium
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
CN103305579B (zh) * 2013-06-29 2014-08-27 吉林大学 一种玉米源辅助增强记忆肽及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
GB2367489A (en) * 2000-07-31 2002-04-10 Mars Inc Anti-oxidant compositions for companion animals
WO2003013268A1 (en) * 2001-08-03 2003-02-20 Mars Uk Limited Foodstuff
JP2004512053A (ja) * 2000-10-31 2004-04-22 コルゲート・パーモリブ・カンパニー ペットフード組成物および方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58129954A (ja) * 1982-01-29 1983-08-03 Riboseren:Kk 新しき健康食品の製造法
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
DE4427079C2 (de) 1994-07-30 2002-12-19 Viatris Gmbh Verfahren zur Racemisierung von Enantiomeren der alpha-Liponsäure
US6184227B1 (en) * 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
US6465466B1 (en) * 1995-12-22 2002-10-15 Leif J. I. Lundblad Uses of indolo-2 [2,3b] -quinoxalines
IT1290907B1 (it) * 1997-01-31 1998-12-14 Idi Farmaceutici Spa Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare.
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
US6858399B2 (en) * 1998-06-29 2005-02-22 Robert Lamb Test for oxidative stress using cell suspensions
US20030198661A1 (en) * 2000-01-31 2003-10-23 Mars Incorporated Antioxidant compositions and methods for companion animals
NZ527924A (en) 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
WO2000057876A1 (en) * 1999-03-26 2000-10-05 Lipogenics, Inc. Novel antioxidant formulations and methods for using them
US6352712B1 (en) * 1999-04-30 2002-03-05 Daniel O. Lukaczer Dietary supplements for treating fatigue-related syndromes
MXPA02002195A (es) 1999-09-09 2002-09-18 Nestle Sa Mejoramiento del estado de mascotas viejas.
US20020077349A1 (en) * 1999-11-03 2002-06-20 Hamilton Nathan D. Method of treating age-related vision impairment
US6207702B1 (en) * 1999-11-17 2001-03-27 Mars, Incorporated Method for reducing postprandial oxidative stress using cocoa procyanidins
AUPQ429399A0 (en) * 1999-11-26 1999-12-23 Heart Research Institute, The Oxidized apolipoproteins and methods of use
WO2001045661A2 (de) * 1999-12-20 2001-06-28 Cognis France, S.A. Kosmetische und/oder pharmazeutische zubereitungen
US20010043983A1 (en) * 2000-01-25 2001-11-22 Hamilton Nathan D. Nutritional supplements for aged pets
CN1423528A (zh) * 2000-04-18 2003-06-11 雀巢制品公司 营养单元
PT1317272E (pt) * 2000-05-25 2006-06-30 Boehringer Ingelheim Int Composicao para melhoramento da proteccao celular compreendendo um antioxidante lipofilo e um antioxidante hidrofilo
US20030036203A1 (en) * 2000-09-26 2003-02-20 Geoff Duke Method and graphic representation for profiling oxidative stress and cardiovascular risk
US20020115710A1 (en) 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
EA006429B1 (ru) 2001-03-09 2005-12-29 Сосьете Де Продюи Нестле С.А. Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
ES2269671T3 (es) * 2001-04-25 2007-04-01 Cobalz Limited Composiciones medicas para su uso en el tratamiento o la prevencion de una insuficiencia de vitamina b12 funcional.
US6596762B2 (en) * 2001-05-17 2003-07-22 The Regents Of The University Of Colorado Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
US20050244422A1 (en) * 2004-04-16 2005-11-03 Desmond Mascarenhas Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
US7247714B2 (en) * 2001-10-16 2007-07-24 Atherogenics, Inc. Protection against oxidative stress and inflammation by a cytoprotective response element
NO323683B1 (no) * 2002-03-14 2007-06-25 Pronova Biocare As Anvendelse av marine og/eller vegetabilske oljer som er behandlet med urea og/eller andre aminer eller amider i fôr til marine arter
JP4771697B2 (ja) * 2002-09-24 2011-09-14 サントリーホールディングス株式会社 認知能力の正常応答の低下予防、改善又は向上作用を有する組成物
US6974841B1 (en) * 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
CA2525560A1 (en) * 2003-05-13 2004-11-25 The Regents Of The University Of Colorado Diagnostic and therapeutic treatments related to mitochondrial disorders
DK1641351T3 (da) 2003-07-03 2014-08-25 Hills Pet Nutrition Inc Sammensætninger og fremgangsmåder til at formindske aldersrelateret forringelse af mental aktivitet hos familiedyr
MXPA06000580A (es) * 2003-07-21 2006-03-30 Unilever Nv Auxiliar de la funcion cognitiva.
US7078202B2 (en) * 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
EP2266586A1 (en) * 2004-03-23 2010-12-29 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
AU2005232392B2 (en) * 2004-04-16 2011-01-06 Société des Produits Nestlé S.A. Method and compositions for reducing oxidative stress in an animal
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US20060094734A1 (en) * 2004-11-04 2006-05-04 Newman Arnold L Composition and method for inducing alertness
RU2433819C2 (ru) 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Применение антиоксидантов для модуляции генов

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
GB2367489A (en) * 2000-07-31 2002-04-10 Mars Inc Anti-oxidant compositions for companion animals
JP2004512053A (ja) * 2000-10-31 2004-04-22 コルゲート・パーモリブ・カンパニー ペットフード組成物および方法
WO2003013268A1 (en) * 2001-08-03 2003-02-20 Mars Uk Limited Foodstuff

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013172732A (ja) * 2006-09-01 2013-09-05 Hill's Pet Nutrition Inc 動物用食物組成物を設計するための方法およびシステム
JP2011528556A (ja) * 2008-07-18 2011-11-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢の動物の生活の質を向上させるための方法
JP2011528555A (ja) * 2008-07-18 2011-11-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢の動物の生活の質を向上させるための方法
JP2015077139A (ja) * 2008-07-18 2015-04-23 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢の動物の生活の質を向上させるための方法
JP2015091246A (ja) * 2008-07-18 2015-05-14 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢の動物の生活の質を向上させるための方法
JP2012513766A (ja) * 2008-12-30 2012-06-21 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルにおける変性関節病、骨関節炎、軟骨損傷、および関連する障害を処置する、または予防する方法
JP2012513767A (ja) * 2008-12-30 2012-06-21 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド リポ酸を含むコンパニオンアニマル用組成物およびその使用の方法
JP2015109850A (ja) * 2008-12-30 2015-06-18 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルにおける変性関節病、骨関節炎、軟骨損傷、および関連する障害を処置する、または予防する方法
JP2015119710A (ja) * 2008-12-30 2015-07-02 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド リポ酸を含むコンパニオンアニマル用組成物およびその使用の方法
JP2013532128A (ja) * 2010-05-12 2013-08-15 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 愛玩動物の炎症を抑制および予防し、炎症状態を緩和する方法
JP2015071633A (ja) * 2010-05-12 2015-04-16 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 愛玩動物の炎症を抑制および予防し、炎症状態を緩和する方法
JP2014018172A (ja) * 2012-07-20 2014-02-03 Kohjin Life Sciences Co Ltd 過酸化脂質生成を抑制するペットフード

Also Published As

Publication number Publication date
AU2005304546A1 (en) 2006-05-18
CN101098623A (zh) 2008-01-02
CA2586936A1 (en) 2006-05-18
US11077165B2 (en) 2021-08-03
EP1814394A4 (en) 2009-08-19
EP1814394A2 (en) 2007-08-08
CN102784396A (zh) 2012-11-21
WO2006053010A2 (en) 2006-05-18
US20080069834A1 (en) 2008-03-20
AU2005304546B2 (en) 2011-07-21
RU2433819C2 (ru) 2011-11-20
RU2007121735A (ru) 2008-12-20
CN102784396B (zh) 2015-07-29
BRPI0517563A (pt) 2008-10-14
CN101098623B (zh) 2012-10-10
ZA200704210B (en) 2008-09-25
CA2586936C (en) 2019-08-20
WO2006053010A3 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
JP2008519838A (ja) 遺伝子調節のための酸化防止剤の使用
US8759283B2 (en) Methods for detecting mRNA and/or protein levels of gene in a biological sample
CN1578627A (zh) 组合物和方法
Feng et al. Changes in barrier health status of the gill for grass carp (Ctenopharyngodon idella) during valine deficiency: regulation of tight junction protein transcript, antioxidant status and apoptosis-related gene expression
AU2009270712B2 (en) Method for enhancing the quality of life of a senior animal
CN103349184A (zh) 用于增加动物的抗氧化状态的组合物和方法
AU2009335096A1 (en) Companion animal compositions including lipoic acid and methods of use thereof
EP1906912A4 (en) PROCESS FOR EXTENDING ANIMAL LIFE
Weber et al. Effects of manganese (Mn) on the developing rat brain: oxidative-stress related endpoints
Ranard et al. Synthetic α-tocopherol, compared with natural α-tocopherol, downregulates myelin genes in cerebella of adolescent Ttpa-null mice
JP5731395B2 (ja) 愛玩動物において抗ウイルス性免疫を増強する際に使用するための、抗酸化剤を含有する食物組成物
AU2013200758B2 (en) Methods for enhancing the quality of life of a senior animal
AU2016200420B2 (en) Companion animal compositions including lipoic acid and methods of use thereof
CA2862200A1 (en) Methods for enhancing the quality of life of a senior animal
AU2013209364A1 (en) Companion animal compositions including lipoic acid and methods of use thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081110

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110620

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110912

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110920

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110928

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111020

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111121

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20121009